Research Site

Akita 010-8543

1 studies enrolling now · 6 studies all time

What they study most

Advanced Clear Cell Renal Cell Carcinoma, Breast Cancer, Eligible Men or Women Considered High Risk for Atherosclerotic Cardiovascular Disease (CVD), Eosinophilic Esophagitis, Metastatic Clear Cell Renal Cell Carcinoma, Thrombotic Microangiopathy, Urothelial Cancer

Studies at this site

• Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma — Recruiting now
• Efficacy and Safety of Tezepelumab in Patients With Eosinophilic Esophagitis — Running, not enrolling
• Study of MEDI4736 (Durvalumab) With or Without Tremelimumab Versus Standard of Care Chemotherapy in Urothelial Cancer — Running, not enrolling
• A Phase III Randomised Study to Evaluate Dato-DXd and Durvalumab for Neoadjuvant/Adjuvant Treatment of Triple-Negative or Hormone Receptor-low/HER2-negative Breast Cancer — Running, not enrolling
• Ravulizumab in Thrombotic Microangiopathy After Hematopoietic Stem Cell Transplant — Completed
• Outcomes Study to Assess STatin Residual Risk Reduction With EpaNova in HiGh CV Risk PatienTs With Hypertriglyceridemia — Completed